Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro

Tumori

Volumn 96, Issue 5, 2010, Pages 744-750

  Chen, Li ^a   Yuan, Daiyue ^a   Zhao, Ren ^b   Li, Hui ^a   Zhu, Jianwei ^a  

^a NANTONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cell cycle; Colorectal cancer; Immunofluorescence; Invasion; MTT; RT PCR; TSPAN1

Indexed keywords

MATRIGEL; POLYCARBONATE; SMALL INTERFERING RNA; TETRASPANIN; TSPAN1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 78650446231     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600517     Document Type: Article

References (29)

1. Parkin D M, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin, 55: 74-108, 2005.
2. Moghimi-Dehkordi B, Safaee A, Zali M R: Comparison of colorectal and gastric cancer: survival and prognostic factors. Saudi J Gastroenterol, 15: 18-23, 2009.
3. Mazzocca A, Carloni V, Sciammetta S, Cordella C, Pantaleo P, Caldini A, Gentilini P, Pinzani M: Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. J Hepatol, 37: 322-330, 2002. (Pubitemid 34969948)
4. Furuya M, Kato H, Nishimura N, Ishiwata I, Ikeda H, Ito R, Yoshiki T, Ishikura H: Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets. Cancer Res, 65: 2617-2625, 2005.
5. Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Köhrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Cuong HV: CD82, and CD63 in thyroid cancer. Int J Mol Med, 14: 517-527, 2004.
6. Odintsova E, Berditchevski F: Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells. Breast Cancer Res, 8: S11-S12, 2006.
7. Klosek SK, Nakashiro K, Hara S, Goda H, Hasegawa H, Hamakawa H: CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Biochem Biophys Res Commun, 379: 1097-1100, 2009.
8. Serru V, Dessen P, Boucheix C, Rubinstein E: Sequence and expression of seven new tetraspans. Biochim Biophys Acta, 1478: 159-163, 2000. (Pubitemid 30136148)
9. Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, O'Keane C, Doran P, Macmathuna P: Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer, 94: 1204-1212, 2006.
10. Wollscheid V, Kuhne-Heid R, Stein I, Jansen L, Kollner S, Schneider A, Durst M: Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas. Int J Cancer, 99: 771-775, 2002. (Pubitemid 34575692)
11. Chen L, Wang Z, Zhan X, Li DC, Zhu YY, Zhu J: Association of NET-1 gene expression with human hepatocellular carcinoma. Int J Surg Pathol, 15: 346-353, 2007. (Pubitemid 47476082)
12. Scholz C J, Kurzeder C, Koretz K, Windisch J, Kreienberg R, Sauer G, Deissler H: Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett, 275: 198-203, 2009.
13. Chen L, Li X, Wang GL, Wang Y, Zhu YY, Zhu J: Clinico-pathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori, 94: 531-538, 2008.
14. Chen L, Zhu YY, Zhang XJ, Wang GL, Li XY, He S, Zhang JB, Zhu JW: TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma. World J Gastroenterol, 15: 2270-2276, 2009.
15. Lee S, Bang S, Song K, Lee I: Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep, 16: 747-754, 2006.
16. Murray D, Horgan G, Macmathuna P, Doran P: NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer, 99: 1322-1329, 2008.
17. Huang C, Li M, Chen C, Yao Q: Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets, 12: 637-645, 2008. (Pubitemid 351699481)
18. Sui G, Soohoo C, Affar EB, Gay F, Shi Y, Forrester WC, Shi Y: A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A, 99: 5515-5520, 2002.
19. Mittal V: Improving the efficiency of RNA interference in mammals. Nat Rev Genet, 5: 355-365, 2004. (Pubitemid 38529407)
20. Rao D D, Vorhies JS, Senzer N, Nemunaitis J: siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev, 61: 746-759, 2009.
21. Shen SQ, Li K, Zhu N, Nakao A: Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol, 25: 341-345, 2008.
22. Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, Satoh S, Kobayashi N, Yamaoka Y, Miyake M: Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer, 89: 158-167, 2003.
23. He B, Liu L, Cook GA, Grgurevich S, Jennings LK, Zhang XA: Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha 6-mediated cell adhesion. J Biol Chem, 280: 3346-3354, 2005.
24. Zöller M: Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer, 9: 40-55, 2009.
25. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M: Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med, 177: 1231-1237, 1993.
26. Hemler ME: Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol, 6: 801-811, 2005.
27. Levy S, Shoham T: Protein-protein interactions in the tetraspanin web. Physiology (Bethesda), 20: 218-224, 2005.
28. Murayama Y, Shinomura Y, Oritani K, Miyagawa J, Yoshida H, Nishida M, Katsube F, Shiraga M, Miyazaki T, Nakamoto T, Tsutsui S, Tamura S, Higashiyama S, Shimomura I, Hayashi N: The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol, 216: 135-143, 2008.
29. Berditchevski F, Odintsova E, Sawada S, Gilbert E: Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J Biol Chem, 277: 36991-37000, 2002.